Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-46,627
Closed -$3.34M 150
2021
Q4
$3.34M Sell
46,627
-146,199
-76% -$11.1M 0.03% 392
2021
Q3
$13.8M Buy
192,826
+7,807
+4% +$616K 0.11% 82
2021
Q2
$15.1M Buy
185,019
+133,898
+262% +$10.8M 0.13% 69
2021
Q1
$3.86M Buy
+51,121
New +$3.72M 0.06% 330

Other funds holding NGVT

UBS O'Connor's NGVT Position: Q1 2022 in Review

UBS O'Connor sold out of Ingevity (NGVT) in Q1 2022, closing a stake of 46,627 shares — an estimated $3.34M sold.

UBS O'Connor first reported a position in NGVT in Q1 2021 and held it in 4 quarters. The position peaked at $15.1M in Q2 2021. 274 funds tracked by Wall St. Rank hold NGVT as of Q1 2022.

  • UBS O'Connor reported no remaining Ingevity position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 46,627 Ingevity shares in Q1 2022, an estimated $3.34M.
  • UBS O'Connor first reported a position in Ingevity in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Ingevity position peaked at $15.1M in Q2 2021.
  • 274 funds tracked by Wall St. Rank held Ingevity as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.